- In January 2025, the Drug and Food Control Organization, under the guidance of the State Drug Controller Jammu & Kashmir, organized an awareness cum orientation program at the Drug Testing Laboratory of Dalgate. The program was launched to train regulators on new tools and techniques for detecting software violations
- In January 2025, Northlane Capital Partners (NCP) announced an investment in the United States Drug Testing Laboratories, Inc. (USDTL). USDTL is a forensic toxicology testing lab for alcohol and substance use. The investment was made to expand their network and niche testing capabilities
- In February 2024, Veriteque USA has entered a distribution agreement with OraSure Technologies, allowing OraSure to offer Veriteque's SwabTek surface test kits alongside its oral fluid drug screening products. SwabTek provides single-use, dry reagent tests for narcotics and explosives, making drug identification accessible for home, educational, and workplace use. This partnership broadens OraSure's drug testing portfolio and enhances its ability to offer comprehensive solutions to businesses, educators, and security professionals.
- In April 2023, MIP Discovery launched its first drugs of abuse reagent, targeting norfentanyl, the main urinary metabolite of fentanyl, addressing the growing synthetic opioid crisis. Using their nanoMIP technology, which is sensitive and robust, MIP Discovery aims to support the development of portable, field-based tests for detecting fentanyl metabolites. This innovation comes as synthetic opioids, including fentanyl, contribute to increasing overdose deaths. The company is committed to reducing synthetic opioid-induced fatalities through advanced detection solutions
- In September 2023, BRITISH CANNABIS acquired PhytoVista Laboratories, a UKAS-accredited cannabinoid testing lab, ensuring its continued operation and upholding regulatory compliance. PhytoVista specializes in cannabinoid analysis, terpene content, and product safety, providing essential testing for CBD and medical cannabis. PhytoVista ensures compliance with UK Home Office regulations for THC testing, aiming to promote higher standards in cannabinoid testing, consumer safety, and industry trust in the growing cannabis market
